Chronic encephalitides as causes of epilepsy: Pathogenesis, diagnosis and treatment;Chronische enzephalitiden als epilepsieursachen: Pathogenese, diagnostik und therapie

Aktuelle Neurologie

Volumn 35, Issue 5, 2008, Pages 214-224

  Bien, Christian G ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Anti NMDA receptor encephalitis; Epilepsy; Limbic encephalitis; Rasmussen's encephalitis; SREAT

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PREDNISOLONE; PREDNISONE; STEROID; TACROLIMUS;

BRAIN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; ENCEPHALITIS; EPILEPSY; EPILEPTIC STATE; HASHIMOTO ENCEPHALOPATHY; HUMAN; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; RASMUSSEN SYNDROME; REVIEW; TREATMENT CONTRAINDICATION;

EID: 46449111499     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1067419     Document Type: Review

References (92)

1. Oguni H, Andermann F, Rasmussen TB. The syndrome of chronic encephalitis and epilepsy. A study based on the MNI series of 48 cases. Adv Neurol 1992; 57: 419-433
2. Bien CG, Widman G, Urbach H et al. The natural history of Rasmussen's encephalitis. Brain 2002; 125: 1751-1759
3. Hart YM, Andermann F, Fish DR et al. Chronic encephalitis and epilepsy in adults and adolescents: a variant of Rasmussen's syndrome? Neurology 1997; 48: 418-424
4. Hennessy MJ, Koutroumanidis M, Dean AF et al. Chronic encephalitis and temporal lobe epilepsy: A variant of Rasmussen's syndrome? Neurology 2001; 56: 678-681
5. Bien CG, Figer CE, Leitner Y et al. Slowly progressive hemiparesis in childhood as a consequence of Rasmussen encephalitis without or with delayed-onset seizures. Eur J Neurol 2007; 14: 387-390
6. Bhatjiwale MG, Polkey C. Cox TC et al. Rasmussen's encephalitis: neuroimaging findings in 21 patients with a closer look at the basal ganglia. Pediatr Neurosurg 1998; 29: 142-148
7. Frucht S. Dystonia, athetosis, and epilepsia partialis continua in a patient with late-onset Rasmussen's encephalitis. Mov Disord 2002; 17: 609-612
8. Hart YM, Andermann F, Robitaille Y et al. Double pathology in Rasmussen's syndrome: a window on the etiology? Neurology 1998; 50: 731-735
9. Farrell MA, Droogan O, Secor DL et al. Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol Berl 1995; 89: 313-321
10. Li Y, Uccelli A, Laxer KD et al. Local-clonal expansion of infiltrating T lymphocytes in chronic encephalitis of Rasmussen. J Immunol 1997; 158: 1428-1437
11. Bien CG, Bauer J, Deckwerth TL et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 2002; 51: 311-318
12. Bauer J, Elger CE, Hans VH et al. Astrocytes are a specific immunological target in Rasmussen's encephalitis. Ann Neurol 2007; 62: 67-80
13. Bien CG, Granata T, Antozzi C et al. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain 2005; 128: 454-471
14. Wiendl H, Bien CG, Bernasconi P et al. GluR3 antibodies: Prevalence in focal epilepsy but no specificity for Rasmussen's encephalitis. Neurology 2001; 57: 1511-1514
15. Mantegazza R, Bernasconi P, Baggi F et al. Antibodies against GluR3 peptides are not specific for Rasmussen's encephalitis but are also present in epilepsy patients with severe, early onset disease and intractable seizures. J Neuroimmunol 2002; 131: 179-185
16. Watson R, Jiang Y, Bermudez I et al. Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 2004; 63: 43-50
17. Oguni H, Andermann F, Rasmussen TB. The natural history of the syndrome of chronic encephalitis and epilepsy: a study of the MNI series of forty-eight cases. In: Andermann F (ed): Chronic encephalitis and epilepsy. Rasmussen's syndrome. Chapt 2. Boston: Butterworth-Heinemann, 1991: 7-35
18. Rasmussen T, McCann W. Clinical studies of patients with focal epilepsy due to "chronic encephalitis". Trans Am Neurol Assoc 1968; 93: 89-94
19. Rasmussen T. Further observations on the syndrome of chronic encephalitis and epilepsy. Appl Neurophysiol 1978; 41: 1-12
20. Grenier Y, Antel JP, Osterland CK. Immunologic studies in chronic encephalitis of Rasmussen. In: Andermann F (ed): Chronic encephalitis and epilepsy. Rasmussen's syndrome. Chapt 9. Boston: Butterworth-Heinemann, 1991: 125-134
21. Dulac O, Robain O, Chiron C et al. High-dose steroid treatment of epilepsia partialis continua due to chronic focal encephalitis. In: Andermann F (ed): Chronic Encephalitis and Epilepsy. Rasmussen's Syndrome. Chapt 16. Boston: Butterworth-Heinemann, 1991: 193-199
22. Granata T, Gobbi G, Spreafico R et al. Rasmussen's encephalitis: early characteristics allow diagnosis. Neurology 2003; 60: 422-425
23. Chiapparini L, Granata T, Farina L et al. Diagnostic imaging in 13 cases of Rasmussen's encephalitis: can early MRI suggest the diagnosis? Neuroradiology 2003; 45: 171-183
24. Granata T, Fusco L, Gobbi G et al. Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology 2003; 61: 1807-1810
25. Dubeau F, Andermann F. Postencephalitic epilepsy. Epilepsia 1992; 33, Suppl 3: 128
26. Jubiz W, Meikle AW. Alterations of glucocorticoid actions by other drugs and disease states. Drugs 1979; 18: 113-121
27. Brooks PM, Buchanan WW, Grove M, Downie WW. Effects of enzyme induction on metabolism of prednisolone. Clinical and laboratory study. Ann Rheum Dis 1976; 35: 339-343
28. Brooks SM, Werk EE, Ackerman SJ et al. Adverse effects of phenobarbital on corticosteroid metabolism in patients with bronchial asthma. N Engl J Med 1972; 286: 1125-1128
29. McLelland J, Jack W. Phenytoin/dexamethasone interaction: A clinical problem. Lancet 1978; 1: 1096-1097
30. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2003; 2: 473-481
31. Bien CG, Elger CE. Chronische limbische Enzephalitiden [Chronic limbic encephalitides]. Akt Neurol 2006; 33: 553-559
32. Iranzo A, Graus F, Clover L et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol 2005; 59: 178-181
33. Liguori R, Vincent A, Clover L et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain 2001; 124: 2417-2426
34. Josephs KA, Silber MH, Fealey RD et al. Neurophysiologic studies in Morvan syndrome. J Clin Neurophysiol 2004; 21: 440-445
35. Brierley JB, Corsellis JAN, Hierons R, Nevin S. Subacute encephalitis of later adult life mainly affecting the limbic areas. Brain 1960; 83: 357-368
36. Gultekin SH, Rosenfeld MR, Voltz R et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000; 123; 1481-1494
37. Tattevin P, Schortgen F, de Broucker T et al. Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis 2001; 33: 786-788
38. Wainwright MS, Martin PL, Morse RP et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol 2001; 50: 612-619
39. Seeley WW, Marty FM, Holmes TM et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6. Neurology 2007; 69: 156-165
40. Graus F, Delattre JY, Antoine JC et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75: 1135-1140
41. Vincent A, Buckley C, Schott JM et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004; 127: 701-712
42. Bower SP, Vogrin SJ, Morris K et al. Amygdala volumetry in "imaging-negative" temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 2003; 74: 1245-1249
43. Nohria V, Lee N, Tien RD et al. Magnetic resonance imaging evidence of hippocampal sclerosis in progression: a case report. Epilepsia 1994; 35: 1332-1336
44. Tien RD, Felsberg GJ. The hippocampus in status epilepticus: demonstration of signal intensity and morphologic changes with sequential fast spin-echo MR imaging. Radiology 1995; 194: 249-256
45. Wieshmann UC, Woermann FG, Lemieux L et al. Development of hippocampal atrophy: a serial magnetic resonance imaging study in a patient who developed epilepsy after generalized status epilepticus. Epilepsia 1997; 38: 1238-1241
46. Fujikawa DG, Itabashi HH, Wu A, Shinmei SS. Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 2000; 41: 981-991
47. Nixon J, Bateman D, Moss T. An MRI and neuropathological study of a case of fatal status epilepticus. Seizure 2001; 10: 588-591
48. Urbach H, Sassen R, Soeder BM et al. Serial MRI in patients with acquired hippocampal sclerosis. Clin Neuroradiol 2006; 16: 47-52
49. Fauser S, Schulze-Bonhage A. How large must an epileptic focus be to cause an electrographic status epilepticus - a case report. Clin Neurophysiol 2004; 115: 2274-2279
50. Fakhoury T, Abou-Khalil B, Kessler RM. Limbic encephalitis and hyperactive foci on PET scan. Seizure 1999; 8: 427-431
51. Kassubek J, Juengling FD, Nitzsche EU, Lücking CH. Limbic encephalitis investigated by 18FDG-PET and 3D MRI. J Neuroimaging 2001; 11: 55-59
52. Scheid R, Lincke T, Voltz R et al. Serial 18F-fluoro-2-deoxy-D- glucose positron emission tomography and magnetic resonance imaging of paraneoplastic limbic encephalitis. Arch Neurol 2004; 61: 1785-1789
53. Fauser S, Talazko J, Wagner K et al. FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology. Acta Neurol Scand 2005; 111: 338-343
54. Lee BY, Newberg AB, Liebeskind DS et al. FDG-PET findings in patients with suspected encephalitis. Clin Nucl Med 2004; 29: 620-625
55. Chugani HT, Shewmon DA, Khanna S, Phelps ME. Interictal and postictal focal hypermetabolism on positron emission tomography. Pediatr Neurol 1993; 9: 10-15
56. Scott RC, Gadian DG, King MD et al. Magnetic resonance imaging findings within 5 days of status epilepticus in childhood. Brain 2002; 125: 1951-1959
57. Urbach H, Soeder BM, Jeub M et al. Serial MRI of limbic encephalitis. Neuroradiology 2006; 48: 380-386
58. Graus F, Ribalta T, Campo E et al. Immunohistochemical analysis of the immune reaction in the nervous system in paraneoplastic encephalomyelitis. Neurology 1990; 40: 219-222
59. Panegyres PK, Reading MC, Esiri MM. The inflammatory reaction of paraneoplastic ganglionitis and encephalitis: an immunohistochemical study. J Neurol 1993; 240: 93-97
60. Hormigo A, Dalmau J, Rosenblum MK et al. Immunological and pathological study of anti-Ri-associated encephalopathy. Ann Neurol 1994; 36: 896-902
61. Verschuuren J, Chuang L, Rosenblum MK et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo-associated paraneoplastic cerebellar degeneration. Acta Neuropathol (Berl) 1996; 91: 519-525
62. Giometto B, Marchiori GC, Nicolao P et al. Sub-acute cerebellar degeneration with anti-Yo autoantibodies: immunohistochemical analysis of the immune reaction in the central nervous system. Neuropathol Appl Neurobiol 1997; 23: 468-474
63. Drlicek M, Bodenteich A, Setinek U et al. T cell-mediated paraneoplastic ganglionitis - An autopsy case. Acta Neuropathol (Berl) 2000; 99: 599-602
64. Bernai F, Graus F, Pifarre A et al. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol (Berl) 2002; 103: 509-515
65. Plonquet A, Gherardi RK, Creange A et al. Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome. J Neuroimmunol 2002; 122: 100-105
66. Wessig C, Klein R, Schneider MF et al. Neuropathology and binding studies in anti-amphiphysin-associated stiff-person syndrome. Neurology 2003; 61: 195-198
67. Blumenthal DT, Salzman KL, Digre KB et al. Early pathologic findings and long-term improvement in anti-Ma2-associated encephalitis. Neurology 2006; 67: 146-149
68. Dunstan EJ, Winer JB. Autoimmune limbic encephalitis causing fits, rapidly progressive confusion and hyponatraemia. Age Ageing 2006; 35: 536-537
69. Park DC, Murman DL, Perry KD, Bruch LA. An autopsy case of limbic encephalitis with voltage-gated potassium channel antibodies. Eur J Neurol 2007; 14: e5-e6
70. Bien CG, Schulze-Bonhage A, Decken M et al. Limbic encephalitis not associated with neoplasm as a cause of temporal lobe epilepsy. Neurology 2000; 55: 1823-1828
71. Bien CG, Urbach H, Schramm J et al. Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 2007; 69: 1236-1244
72. Keime-Guibert F, Graus F, Broet P et al. Clinical outcome of patients with anti-Hu-associated encephalomyelitis after treatment of the tumor. Neurology 1999; 53: 1719-1723
73. Keime-Guibert F, Graus F, Fleury A et al. Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone. J Neurol Neurosurg Psychiatry 2000; 68: 479-482
74. Blaes F, Rauer S, Voltz R, Weller M. Paraneoplastische Syndrome. Leitlinien der Deutschen Gesellschaft für Neurologie 2007. http://www.dgn.org/109.0.html?&no_cache=1&sword_list[]=paraneoplastisch (Zugang zur Website erfolgte am 05.04.2008)
75. Thieben MJ, Lennon VA, Boeve BF et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004; 62: 1177-1182
76. Mori M, Kuwabara S, Yoshiyama M et al. Successful immune treatment for non-paraneoplastic limbic encephalitis. J Neurol Sci 2002; 201: 85-88
77. Dalmau J, Tüzün E, Wu HY et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007; 61: 25-36
78. Dalmau J, Tüzün E, Wu HY et al. Supplementmaterial zu Dalmau et al. Ann Neurol 2007; 61: 25-36 verfügbar über http://www.mrw.interscience.wiley.com/suppmat/0364-5134/suppmat/ana.21050.html Zugriff auf die Website erfolgte am 04.04.2008
79. Tüzün E, Dalmau J. Limbic encephalitis and variants: classification, diagnosis and treatment. Neurologist 2007; 13: 261-271
80. Iizuka T, Sakai F, Ide T et al. Anti-NMDA receptor encephalitis in Japan. Long-term outcome without tumor removal. Neurology 2007; 70: 504-511
81. Novillo-López ME, Rossi JE, Dalmau J, Masjuan J. Treatment-responsive subacute limbic encephalitis and NMDA receptor antibodies in a man. Neurology 2008; 70: 728-729
82. Mocellin R, Walterfang M, Velakoulis D. Hashimoto's Encephalopathy: Epidemiology, Pathogenesis and Management. CNS Drugs 2007; 21: 799-811
83. Kothbauer-Margreiter I, Sturzenegger M, Komor J et al. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 1996; 243: 585-593
84. Solimena M, Folli F, Aparisi R et al. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990; 322: 1555-1560
85. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499
86. Castillo P, Woodruff B, Caselli R et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis. Arch Neurol 2006; 63: 197-202
87. Schäuble B, Castillo PR, Boeve BF, Westmoreland BF. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol 2003; 114: 32-37
88. Nolte KW, Unbehaun A, Sieker H et al. Hashimoto encephalopathy: a brainstem vasculitis? Neurology 2000; 54: 769-770
89. Doherty CP, Schlossmacher M, Torres N et al. Hashimoto's encephalopathy mimicking Creutzfeldt-Jakob disease: brain biopsy findings. J Neurol Neurosurg Psychiatry 2002; 73: 601-602
90. Paulus W, Nolte KW. Neuropathology of Hashimoto's encephalopathy. J Neurol Neurosurg Psychiatry 2003; 74: 1009
91. Mahad DJ, Staugaitis S, Ruggieri P et al. Steroid-responsive encephalopathy associated with autoimmune thyroiditis and primary CNS demyelination. J Neurol Sci 2005; 228: 3-5
92. Binder DK, Schramm J. Transsylvian functional hemispherectomy. Childs Nerv Syst 2006; 22: 960-966